SG Americas Securities
BEAM icon

SG Americas Securities’s Beam Therapeutics BEAM Stock Holding History

SG Americas Securities’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.31M Sell
38,287
-21,893
-36% -$661K ﹤0.01% 1714
2026
Q1 		$1.43M Sell
60,180
-43,289
-42% -$1.2M ﹤0.01% 1549
2025
Q4 		$2.87M Buy
103,469
+60,249
+139% +$1.54M ﹤0.01% 1345
2025
Q3 		$1.05M Buy
43,220
+36,004
+499% +$716K ﹤0.01% 1414
2025
Q2 		$123K Sell
7,216
-8,822
-55% -$154K ﹤0.01% 2546
2025
Q1 		$313K Buy
16,038
+3,920
+32% +$103K ﹤0.01% 2177
2024
Q4 		$301K Buy
12,118
+1,971
+19% +$50.3K ﹤0.01% 1792
2024
Q3 		$249K Sell
10,147
-8,995
-47% -$232K ﹤0.01% 2306
2024
Q2 		$448K Buy
19,142
+13,018
+213% +$320K ﹤0.01% 1729
2024
Q1 		$202K Sell
6,124
-8,720
-59% -$272K ﹤0.01% 1968
2023
Q4 		$404K Sell
14,844
-254
-2% -$6.31K ﹤0.01% 1614
2023
Q3 		$363K Buy
+15,098
New +$405K ﹤0.01% 1969
2023
Q2 		– Sell
-16,277
Closed -$498K – 2329
2023
Q1 		$498K Buy
16,277
+12,090
+289% +$477K 0.01% 1723
2022
Q4 		$164K Sell
4,187
-3,578
-46% -$160K ﹤0.01% 2348
2022
Q3 		$370K Sell
7,765
-20,418
-72% -$1.16M ﹤0.01% 1810
2022
Q2 		$1.09M Buy
28,183
+22,566
+402% +$897K 0.01% 1230
2022
Q1 		$322K Sell
5,617
-8,985
-62% -$589K ﹤0.01% 2154
2021
Q4 		$1.16M Sell
14,602
-6,065
-29% -$519K 0.01% 1535
2021
Q3 		$1.8M Buy
20,667
+8,440
+69% +$848K 0.01% 1372
2021
Q2 		$1.57M Buy
12,227
+1,281
+12% +$102K 0.01% 1273
2021
Q1 		$876K Buy
+10,946
New +$1.04M ﹤0.01% 1641
2020
Q3 		– Sell
-6,866
Closed -$192K – 2734
2020
Q2 		$192K Buy
+6,866
New +$148K ﹤0.01% 2889

Other funds holding BEAM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

SG Americas Securities's BEAM Position: Q2 2026 in Review

SG Americas Securities reduced its Beam Therapeutics (BEAM) stake by 36% in Q2 2026, selling an estimated $661K and leaving 38,287 shares worth $1.31M. The position accounts for ﹤0.01% of the portfolio, ranked #1714.

SG Americas Securities first reported a position in BEAM in Q2 2020 and has held it in 22 quarters since. The position peaked at $2.87M in Q4 2025. 277 funds tracked by Wall St. Rank hold BEAM as of Q2 2026.

  • SG Americas Securities held 38,287 shares of Beam Therapeutics worth $1.31M as of Q2 2026.
  • SG Americas Securities sold 21,893 Beam Therapeutics shares in Q2 2026, an estimated $661K.
  • Beam Therapeutics made up ﹤0.01% of SG Americas Securities's portfolio in Q2 2026, its #1714 holding.
  • SG Americas Securities first reported a position in Beam Therapeutics in Q2 2020 and has held it in 22 quarters since.
  • SG Americas Securities's Beam Therapeutics position peaked at $2.87M in Q4 2025.
  • 277 funds tracked by Wall St. Rank held Beam Therapeutics as of Q2 2026.

Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.